The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nel, A. E.
Right arrow Articles by Landreth, G. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nel, A. E.
Right arrow Articles by Landreth, G. E.

The Journal of Immunology, Vol 144, Issue 7 2683-2689, Copyright © 1990 by American Association of Immunologists


ARTICLES

Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C

AE Nel, C Hanekom, A Rheeder, K Williams, S Pollack, R Katz and GE Landreth
Department of Medicine, UCLA School of Medicine 90024-1680.

Signaling via the alpha-beta T cell Ag receptor (Ti)-CD3 complex is a complicated event that implicates several protein kinases, most notably protein kinase C (PKC). We have recently identified a serine kinase in T lymphocytes with the following characteristics: molecular mass 43 kDa, in vitro substrate affinity for microtubule associated protein 2 (MAP-2) with a preference for Mn2+ during the catalytic reaction, and elution from DEAE resin over a salt range 100 to 200 mM NaCl. This kinase is activated in a rapidly reversible fashion during ligation of CD3/Ti by a process which involves prior phosphorylation; in vitro exposure of activated 43-kDa MAP-2 kinase (MAP-K) to an immobilized phosphatase abrogated its kinase activity. We now show that a MAP-2K response could also be obtained during treatment with mAb to Ti and the specific PKC agonist, PMA. Although the kinetics of the former response was rapidly reversible, PMA elicited a more prolonged response. The dose responsiveness for PMA was similar to the requirements for PKC activation in intact lymphocytes. Moreover, as with PKC, we found that the CD3-induced MAP-2K response could be further enhanced by using a second layer cross-linking antibody. The specificity of CD3/Ti in the Jurkat cell response is demonstrated by the fact that OKT-11(CD2) and anti-CD4 mAb did not stimulate a MAP-2K response. It was also not possible to elicit a response in a Jurkat cell mutant that lacks surface expression of CD3 and Ti. The specificity of PKC in these events was further explored with the cell permeant diacylglycerol, 1- oleoyl-2-acetylglycerol, and the nonagonist phorbol ester, 4 alpha- phorbol 12,13-didecanoate: whereas the former was an effective inducer of the MAP-2K response, the latter failed to yield any stimulation. Prior exposure of Jurkat cells to 100 mM PMA for 24 h eliminated greater than 60% of the MAP-2K response during anti-CD3 treatment. This response could also be inhibited in dose-dependent fashion by prior treatment of Jurkat cells with the potent PKC inhibitor 1-(5- isoquinolinesulfonyl) 2-methylpiperazine dihydrochloride. Although a Ca2(+)-ionophore failed to synergize with PMA at inducing a MAP-2K response, depletion of extracellular Ca2+ by EGTA abrogated anti-CD3 responsiveness. The events culminating in MAP-2K activation were slightly inhibited in the presence of cholera toxin but not pertussis toxin.(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
A. Denys, A. Hichami, and N. A. Khan
n-3 PUFAs modulate T-cell activation via protein kinase C-{alpha} and -{varepsilon} and the NF-{kappa}B signaling pathway
J. Lipid Res., April 1, 2005; 46(4): 752 - 758.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. Denys, A. Hichami, and N. A. Khan
Eicosapentaenoic acid and docosahexaenoic acid modulate MAP kinase (ERK1/ERK2) signaling in human T cells
J. Lipid Res., December 1, 2001; 42(12): 2015 - 2020.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Matsuguchi, K. Takagi, T. Musikacharoen, and Y. Yoshikai
Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes
Blood, February 15, 2000; 95(4): 1378 - 1385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. P. Kennedy, A. Sekulic, B. J. Irvin, A. E. Nilson, S. M. Dilworth, and R. T. Abraham
Polyomavirus Middle T Antigen as a Probe for T Cell Antigen Receptor-coupled Signaling Pathways
J. Biol. Chem., May 8, 1998; 273(19): 11505 - 11513.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. H. Holmstrom, S. C. Chow, I. Elo, E. T. Coffey, S. Orrenius, L. Sistonen, and J. E. Eriksson
Suppression of Fas/APO-1-Mediated Apoptosis by Mitogen-Activated Kinase Signaling
J. Immunol., March 15, 1998; 160(6): 2626 - 2636.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Zhao, Y.-Y. Li, R. V. Fucini, S. E. Ross, J. E. Pessin, and G. A. Koretzky
T Cell Receptor-induced Phosphorylation of Sos Requires Activity of CD45, Lck, and Protein Kinase C, but Not ERK
J. Biol. Chem., August 22, 1997; 272(34): 21625 - 21634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Jascur, J. Gilman, and T. Mustelin
Involvement of Phosphatidylinositol 3-Kinase in NFAT Activation in T Cells
J. Biol. Chem., May 30, 1997; 272(22): 14483 - 14488.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Mege, V. Di Bartolo, V. Germain, L. Tuosto, F. Michel, and O. Acuto
Mutation of Tyrosines 492/493 in the Kinase Domain of ZAP-70 Affects Multiple T-cell Receptor Signaling Pathways
J. Biol. Chem., December 20, 1996; 271(51): 32644 - 32652.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. R. Butch and K.-L. Guan
Characterization of ERK1 Activation Site Mutants and the Effect on Recognition by MEK1 and MEK2
J. Biol. Chem., February 23, 1996; 271(8): 4230 - 4235.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
AndrE. Nel, S. Gupta, L. Lee, J. A. Ledbetter, and S. B. Kanner
Ligation of the T-cell Antigen Receptor (TCR) Induces Association of hSos1, ZAP-70, Phospolipase C-[IMAGE]1, and Other Phosphoproteins with Grb2 and the [IMAGE]-Chain of the TCR
J. Biol. Chem., August 4, 1995; 270(31): 18428 - 18436.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-P. Hsueh and M.-Z. Lai
c-Jun N-terminal Kinase but Not Mitogen-activated Protein Kinase Is Sensitive to cAMP Inhibition in T Lymphocytes
J. Biol. Chem., July 28, 1995; 270(30): 18094 - 18098.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Khalil, C. B. Menice, C.-L. A. Wang, and K. G. Morgan
Phosphotyrosine-Dependent Targeting of Mitogen-Activated Protein Kinase in Differentiated Contractile Vascular Cells
Circ. Res., June 1, 1995; 76(6): 1101 - 1108.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
X. Xu, J. W. Williams, E. G. Bremer, A. Finnegan, and A. S.-F. Chong
Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, Leflunomide
J. Biol. Chem., May 26, 1995; 270(21): 12398 - 12403.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
E Ettehadieh, J. Sanghera, S. Pelech, D Hess-Bienz, J Watts, N Shastri, and R Aebersold
Tyrosyl phosphorylation and activation of MAP kinases by p56lck
Science, February 14, 1992; 255(5046): 853 - 855.
[Abstract] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
A. Weiss, A.C. Chan, M. Iwashima, D. Straus, and B.A. Irving
Regulation of Protein Tyrosine Kinase Activation by the T-cell Antigen Receptor {zeta} Chain
Cold Spring Harb Symp Quant Biol, January 1, 1992; 57(0): 107 - 116.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
A. Alonso, M. Saxena, S. Williams, and T. Mustelin
Inhibitory Role for Dual Specificity Phosphatase VHR in T Cell Antigen Receptor and CD28-induced Erk and Jnk Activation
J. Biol. Chem., February 9, 2001; 276(7): 4766 - 4771.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.